Horan Securities, Inc. Gilead Sciences, Inc. Transaction History

Horan Securities, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $152 - $173	2 Added 0.48%	415 $31,000
Q1 2023 Apr 18, 2023	SELL	$77.31 - $88.08 $3,788 - $4,315	-49 Reduced 10.61%	413 $34,000
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $62 - $89	1 Added 0.22%	462 $0
Q3 2022 Oct 12, 2022	BUY	$59.54 - $68.01 $18,814 - $21,491	316 Added 217.93%	461 $28,000
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $2,886 - $3,250	50 Added 52.63%	145 $9,000
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $1,416 - $1,613	-25 Reduced 20.83%	95 $6,000
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $12,109 - $15,225	-195 Reduced 61.9%	120 $8,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $18,446 - $21,420	255 Added 425.0%	315 $24,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $3,757 - $4,813	60 New	60 $4,000
Q3 2019 Oct 21, 2019	SELL	$62.51 - $69.0 $5,438 - $6,003	-87 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $5,382 - $6,036	87 New	87 $6,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.